1. Home
  2. TGTX vs LNC Comparison

TGTX vs LNC Comparison

Compare TGTX & LNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TG Therapeutics Inc.

TGTX

TG Therapeutics Inc.

HOLD

Current Price

$53.25

Market Cap

8.5B

Sector

Health Care

ML Signal

HOLD

Logo Lincoln National Corporation

LNC

Lincoln National Corporation

HOLD

Current Price

$42.17

Market Cap

7.0B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
TGTX
LNC
Founded
1993
1905
Country
United States
United States
Employees
N/A
9423
Industry
Biotechnology: Pharmaceutical Preparations
Life Insurance
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
8.5B
7.0B
IPO Year
2008
N/A

Fundamental Metrics

Financial Performance
Metric
TGTX
LNC
Price
$53.25
$42.17
Analyst Decision
Strong Buy
Hold
Analyst Count
5
16
Target Price
$49.80
$43.13
AVG Volume (30 Days)
1.9M
1.7M
Earning Date
05-04-2026
05-07-2026
Dividend Yield
N/A
4.87%
EPS Growth
1746.67
N/A
EPS
0.12
N/A
Revenue
$2,785,000.00
N/A
Revenue This Year
$49.08
$9.60
Revenue Next Year
$26.69
$3.73
P/E Ratio
$457.29
$7.17
Revenue Growth
N/A
N/A
52 Week Low
$25.37
$32.18
52 Week High
$59.30
$46.82

Technical Indicators

Market Signals
Indicator
TGTX
LNC
Relative Strength Index (RSI) 51.91 65.51
Support Level $51.15 $38.68
Resistance Level $58.34 $42.68
Average True Range (ATR) 2.23 0.99
MACD -0.57 0.03
Stochastic Oscillator 36.41 82.87

Price Performance

Historical Comparison
TGTX
LNC

About TGTX TG Therapeutics Inc.

TG Therapeutics Inc is a fully integrated, commercial-stage biotechnology company focused on acquiring, developing, and commercializing novel treatments for B-cell diseases. In addition to a research pipeline, TG Therapeutics has received approval from the U.S. Food and Drug Administration (FDA) for BRIUMVI (ublituximab-xiiy) to treat adult patients with relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, as well as approval from several regulatory agencies outside of the U.S. for BRIUMVI to treat adult patients with RMS who have active disease defined by clinical or imaging features.

About LNC Lincoln National Corporation

Lincoln National Corp operates multiple insurance and retirement businesses. The company's operating segment includes Annuities; Retirement Plan Services; Life Insurance and Group Protection. Its products include fixed and indexed annuities, variable annuities, universal life insurance (UL), variable universal life insurance (VUL), linked-benefit UL and VUL, indexed universal life insurance (IUL), term life insurance, employer-sponsored retirement plans and services, and group life, disability, and dental.

Share on Social Networks: